IDEXX (IDXX) Launches Canine Cancer Detection Panel in UK

The sheet offers 79% sensitivity and 99% specificity, providing clinicians with reliable insights that tin see B-cell and T-cell phenotype classification for affirmative results. Beyond archetypal detection, aboriginal information bespeak the trial tin beryllium utilized to show patients during chemotherapy treatments. Each effect includes broad enactment from IDEXX Medical Consultants, including board-certified oncologists, arsenic good arsenic acquisition resources to assistance veterinarians pass findings and adjacent steps to favored owners.

IDEXX Laboratories Inc. (NASDAQ:IDXX) highlighted beardown marketplace request for the product, noting that 71% of UK favored owners person expressed involvement successful crab screening for their pets. Since its 2025 motorboat successful North America, ~6,000 practices person already adopted the technology. Over the adjacent 3 years, the institution plans to grow the panel’s capabilities to screen the bulk of canine crab cases, further advancing its committedness to proactive veterinary crab absorption and intervention.

Photo by Karlo Tottoc connected Unsplash

IDEXX Laboratories Inc. (NASDAQ:IDXX) develops and sells diagnostic products for carnal veterinary, livestock, and poultry, and h2o microbiology testing. The institution covers in-clinic chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers.

While we admit the imaginable of IDXX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.